⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
EPRI Launches Flex MOSAIC to Reduce ‘Time to Power’ for Data Centers
globenewswire.com
GOOGL
NVDA
EXC
DTE
LNT
SO
PCG
EIX
PNW
ETR
PPL
SRE
CMS
NI
AEP
XEL
LUV
HON
SI
LIN
PEG
ECL
FE
WEC
NRG
ED
ES
MDU
NE
UTL
CWEN
BEP
TER
MAS
AMAT
MU
INTC
AMD
CDNS
SNPS
VRTX
GILD
AMGN
BIIB
REGN
AZN
NVS
PFE
MRK
JNJ
ABBV
BMY
LLY
TEVA
BCE
CVE
CP
RY
TD
BNS
CM
CNQ
SU
BHP
RIO
VAL
FCX
AA
STLD
CF
MOS
NTR
ADM
BG
CARR
EMR
GOOG
META
S
VZ
T
TMUS
CCI
AMT
EQIX
DLR
IBM
MSFT
AMZN
CSCO
LRCX
KLAC
ADI
TXN
ON
NXPI
INFY
CTSH
ACN
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
globenewswire.com
CVAC
BNTX
SNY
AMGN
NVS
PFE
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
globenewswire.com
NVS
ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider
globenewswire.com
NVS
LLY
Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program
businesswire.com
NVS
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
globenewswire.com
NVS
Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
globenewswire.com
NVS
LLY
BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
globenewswire.com
PFE
NVS
Bringing His On-Screen Journey to Life, Ricco Ross of Tyler Perry's Netflix Series 'Beauty in Black' Joins ZERO Prostate Cancer as Global Ambassador
prnewswire.com
NVS
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
prnewswire.com
NVS
AZN